In 2014, Silicon Valley-based entrepreneur Joon Yun launched his $1 million Palo Alto Longevity Prize as an incentive to scientists to fix the “problem” of aging. In nearby Novato, Deepak Lamba’s group at the Buck Institute for Research on Aging have been focusing on fixing this problem (or at least the retinal degenerative disorders associated with aging) with stem cell therapy (1).